US Patent 9365610 Asymmetric ionizable cationic lipid for RNA delivery
Patent 9365610 was granted and assigned to Arcturus Therapeutics on June, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+59 characters)
Article
Patent abstract
What is described is a compound of formula I
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David Webb0
Joseph E. Payne0
Padmanabh Chivukula0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09365610 Asymmetric ionizable cationic lipid for RNA delivery US Patent 9365610 Asymmetric ionizable cationic lipid for RNA delivery
Infobox
Patent Number
093656100
Patent Number
93656100
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093656100
Date of Patent
June 14, 2016
0Patent Application Number
147078760
Date Filed
May 8, 2015
0Official Website
Patent Primary Examiner
Edits on 5 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09365610 Asymmetric ionizable cationic lipid for RNA delivery
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09365610
Date of patent
June 14, 2016
Patent application number
14707876
Date Filed
May 8, 2015
Patent primary examiner
Find more entities like US Patent 9365610 Asymmetric ionizable cationic lipid for RNA delivery
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
